Mark your calendar for the 2024 McGuireWoods Healthcare Private Equity and Finance Conference, and help us celebrate 20 years of bringing healthcare industry leaders together. This premier two-day healthcare...more
4/1/2024
/ Acute Facilities ,
Ambulatory Surgery Centers ,
Artificial Intelligence ,
C-Suite Executives ,
Consultants ,
Dental Practice ,
Digital Health ,
Events ,
Health Care Providers ,
Health Technology ,
Healthcare Facilities ,
Investment Banks ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Medical Equipment ,
Mental Health ,
Mezzanine Lenders ,
Pharmaceutical Industry ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Senior Lenders ,
Specialty Healthcare ,
Value-Based Care
McGuireWoods recently held its 16th annual Healthcare Finance & Growth Conference, during which speakers and industry leaders examined various subtopics in the healthcare space....more
Since mid-2022, the macro acquisition environment has faced the challenges of inflation and increasing interest rates, among a variety of other headwinds. Global deal flow is down from its 2021 peak. Yet, as this white paper...more
Episode eight of McGuireWoods’ video series “Healthcare Headlines” is now available. Hosted by McGuireWoods partner Amber McGraw Walsh, a member of the firm’s nationally recognized Healthcare Department, this episode welcomes...more
The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference discusses investing in the life sciences. It is authored by our colleagues Tim Loveland...more
Private equity investment in healthcare has continued to grow considerably from when we examined various niche investment areas on April 11, 2016, in the article titled “Private Equity in Healthcare – A Review of 15 Niche...more
3/29/2018
/ Acquisitions ,
Health Care Providers ,
Hospitals ,
Investment ,
Investors ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
Allena Pharmaceuticals has announced it has secured $53 million in series C financing.
Allena, based in Newton, Mass., is biopharmaceutical company focused on developing and commercializing nonsystemic oral protein...more
Vertice Pharma, which has its U.S. headquarters in New Jersey, will focus on acquiring specialty pharmaceutical companies and products. It was launched by pharmaceutical industry veterans Don DeGolyer and Andrew Saik in...more
Galera, headquartered in Malvern, Pa., is a clinical-stage biotechnology company focused on the development of drugs targeting oxygen metabolic pathways....more
AMO Pharma Limited has announced it has secured $25 million in private equity financing.
AMO Pharma, with offices in Philadelphia and London, is a privately held biopharmaceutical company focusing on debilitating...more
Syndax, based in Waltham, Mass., is a clinical stage biopharmaceutical company. It is developing entinostat, an investigational, targeted, epigenetic immunomodulator, as a combination therapy in multiple cancer indications...more
WAVE Life Sciences, based in Boston, is a genetic medicine company focused on developing stereopure nucleic acid therapies for patients impacted by rare diseases....more
Oncobiologics, based in Cranbury, N.J., is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics....more
Novartis Pharmaceuticals has announced it has formed a joint investment company with Qualcomm Ventures, the venture investment group of Qualcomm....more
1/23/2015
/ Digital Health ,
Funding ,
Healthcare ,
Initial Public Offering (IPO) ,
Joint Venture ,
Novartis ,
Pharmaceutical Industry ,
Popular ,
Qualcomm ,
Startups ,
Venture Funding